0000000000207848

AUTHOR

Patricia Fernandez

showing 8 related works from this author

Top-quark mass measurements using jet rates at LHC

2013

This work presents a new method to measure the top-quark mass in hadronic collisions[1]. The method uses the sensitivity of the tt̄ + 1-jet production on the top-quark mass. In detail we study the ℛ distribution defined as the tt̄ + 1-jet normalized cross section differential in the invariant mass of the total system and calculated at NLO accuracy. We prove that the ℛ distribution has a high sensitivity to the top-quark mass. Furthermore we investigate and quantify the impact of the dominant theoretical and experimental uncertainties. The results obtained show, that the method has the potential to be competitive in precision with established approaches and allows a complementary measurement…

Scattering cross-sectionPhysicsTop quarkParticle physicsLarge Hadron ColliderPhysicsQC1-999HadronHigh Energy Physics::PhenomenologyInvariant (physics)Nuclear physicsRenormalizationPhysics and Astronomy (all)High Energy Physics::ExperimentMass parameterEPJ Web of Conferences
researchProduct

Novel silver-based nanoclay as an antimicrobial in polylactic acid food packaging coatings.

2010

This paper presents a comprehensive performance study of polylactic acid (PLA) biocomposites, obtained by solvent casting, containing a novel silver-based antimicrobial layered silicate additive for use in active food packaging applications. The silver-based nanoclay showed strong antimicrobial activity against Gram-negative Salmonella spp. Despite the fact that no exfoliation of the silver-based nanoclay in PLA was observed, as suggested by transmission electron microscopy (TEM) and wide angle X-ray scattering (WAXS) experiments, the additive dispersed nicely throughout the PLA matrix to a nanoscale, yielding nanobiocomposites. The films were highly transparent with enhanced water barrier …

Materials scienceTime FactorsPolymersHealth Toxicology and MutagenesisPolyestersMetal NanoparticlesNanotechnologyFood ContaminationMicrobial Sensitivity Testsengineering.materialToxicologyPermeabilitychemistry.chemical_compoundPolylactic acidCoatingMicroscopy Electron TransmissionSalmonellaFood PreservationNanotechnologyLactic Acidchemistry.chemical_classificationCalorimetry Differential ScanningSilicatesPublic Health Environmental and Occupational HealthFood preservationFood PackagingTemperatureSilver CompoundsGeneral ChemistryGeneral MedicinePolymerElectrochemical TechniquesAntimicrobialExfoliation jointAnti-Bacterial AgentsFood packagingSteamchemistryChemical engineeringengineeringFood MicrobiologyFood qualityFood ScienceFood additivescontaminants. Part A, Chemistry, analysis, control, exposurerisk assessment
researchProduct

A new observable to measure the top-quark mass at hadron colliders

2013

A new method to measure the top-quark mass in high energetic hadron collisions is presented. We use theoretical predictions calculated at next-to-leading order accuracy in quantum chromodynamics to study the ( normalized) differential distribution of the t (t) over bar + 1-jet cross section with respect to its invariant mass root s(t (t) over barj). The sensitivity of the method to the top-quark mass together with the impact of various theoretical and experimental uncertainties has been investigated and quantified. The new method allows for a complementary measurement of the top-quark mass parameter and has a high potential to become competitive in precision with respect to established appr…

Top quarkParticle physicsPhysics and Astronomy (miscellaneous)HadronFOS: Physical sciences7. Clean energy01 natural sciencesMeasure (mathematics)High Energy Physics - ExperimentRenormalizationHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)0103 physical sciencesInvariant massddc:530Sensitivity (control systems)010306 general physicsEngineering (miscellaneous)Quantum chromodynamicsPhysics010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFísicaObservableHigh Energy Physics - PhenomenologyHiggs-BosonHigh Energy Physics::ExperimentLHCMonte Carlo top quark
researchProduct

Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes

2003

Heme oxygenase-1 (HO-1) is implicated in the protection against tissue injury. We investigated the expression of this protein in cartilage sections and chondrocytes obtained from osteoarthritic patients. HO-1 was immunodetected in preparations from cartilage and also in chondrocytes cultured in the absence of stimulation. We found that HO-1 can be modulated by cytokines since the pro-inflammatory cytokines interleukin (IL)-1beta, IL-17 and tumour necrosis factor-alpha (TNF-alpha) down-regulated this protein, whereas the anti-inflammatory cytokine IL-10 exerted the opposite effect. Our results suggest a role for HO-1 as part of protective mechanisms against tissue injury in human cartilage.

MaleNecrosismedicine.medical_treatmentBiochemistryGene Expression Regulation EnzymologicChondrocytechemistry.chemical_compoundChondrocytesOsteoarthritismedicineHumansHemeAgedPharmacologyRegulation of gene expressionbusiness.industryCartilageInterleukin-17Membrane ProteinsInterleukinInterleukin-10Cell biologyHeme oxygenasemedicine.anatomical_structureCytokinechemistryHeme Oxygenase (Decyclizing)ImmunologyCytokinesFemalemedicine.symptombusinessHeme Oxygenase-1Interleukin-1Biochemical Pharmacology
researchProduct

Anti-inflammatory actions of the heme oxygenase-1 pathway.

2003

Heme oxygenase 1 (HO-1) is induced by oxidative or nitrosative stress, cytokines and other mediators produced during inflammatory processes, likely as part of a defence system in cells exposed to stress to provide a negative feedback for cell activation and the production of mediators, which could modulate the inflammatory response. HO-1 activity results in the inhibition of oxidative damage and apoptosis, with significant reductions in inflammatory events including edema, leukocyte adhesion and migration, and production of inflammatory cytokines. HO-1 is induced by nitric oxide (NO) in different biological systems and can control the increased production of this mediator observed in many i…

Chemokinemedicine.medical_treatmentInflammationmedicine.disease_causeProinflammatory cytokineDrug DiscoverymedicineAnimalsHumansPharmacologyInflammationbiologyChemistryAnti-Inflammatory Agents Non-SteroidalMembrane ProteinsCell biologyHeme oxygenaseCytokineImmunologyHeme Oxygenase (Decyclizing)biology.proteinmedicine.symptomSignal transductionCell activationOxidative stressHeme Oxygenase-1Signal TransductionCurrent pharmaceutical design
researchProduct

Top-quark mass measurements at LHC: a new approach

2013

We present a new method to measure the top-quark mass in high energetic hadron collisions at the LHC. We study the mass dependence of the production of top-quark pairs in association with an additional jet. The cross section of tt+1Jet production is sensitive to the top-quark mass since gluon radiation depends on the top-quark mass through threshold and cone effects. In particular we study the normalised tt +1Jet cross section differential in the invariant mass of the final state jets. We have investigated the sensitivity of the method together with the impact of various theoretical and experimental uncertainties. We find that the method has the potential to be competitive with existing met…

PhysicsHistoryTop quarkParticle physicsLarge Hadron ColliderHigh Energy Physics::LatticeHadronHigh Energy Physics::PhenomenologyJet (particle physics)530 PhysikComputer Science ApplicationsEducationGluonNuclear physicsRenormalizationCross section (physics)Invariant massHigh Energy Physics::Experimentddc:530
researchProduct

Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.

2006

Objective Adenosine regulates inflammation and tissue repair, and adenosine A2A receptors promote wound healing by stimulating collagen matrix production. We therefore examined whether adenosine A2A receptors contribute to the pathogenesis of dermal fibrosis. Methods Collagen production by primary human dermal fibroblasts was analyzed by real-time polymerase chain reaction, 14C-proline incorporation, and Sircol assay. Intracellular signaling for dermal collagen production was investigated using inhibitors of MEK-1 and by demonstration of ERK phosphorylation. In vivo effects were studied in a bleomycin-induced dermal fibrosis model using adenosine A2A receptor–deficient wild-type littermate …

Malemedicine.medical_specialtyReceptor Adenosine A2AImmunologyMAP Kinase Kinase 1Adenosine A2A receptorGene ExpressionBiologyMiceRheumatologyFibrosisInternal medicinemedicineImmunology and AllergyAnimalsHumansPharmacology (medical)RNA MessengerEnzyme InhibitorsReceptorCells CulturedMice Knockoutintegumentary systemTriazinesDermisPurinergic signallingFibroblastsTriazolesAdenosine A3 receptormedicine.diseaseAdenosineAdenosine receptorFibrosisMice Inbred C57BLDisease Models AnimalHydroxyprolineEndocrinologyScleroderma DiffuseCancer researchCollagenWound healingmedicine.drugArthritis and rheumatism
researchProduct

A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis.

2004

ITB (6-(p-bromophenyl)amino-7-(p-chlorophenyl)indazolo[2',3':1,5]-1,2,4-triazolo[4,3-a]-1,3,5-benzotriazepine) is a novel inhibitor of cyclo-oxygenase-2 (COX-2) with antiinflammatory activity in animal models. In the present study, we investigated the effect of this compound on the production of catabolic or antiinflammatory mediators in osteoarthritis (OA) cartilage. In OA cartilage explants, ITB inhibited the production of prostaglandin E(2) (PGE(2)), tumour necrosis factor-alpha (TNF-alpha) and matrix metalloproteinase-13 (MMP-13) in a concentration-dependent manner, whereas nitrite was partially reduced. On the contrary, ITB increased the production of interleukin (IL)-10 and the expres…

MaleOxygenaseIndazolesmedicine.medical_treatmentAnti-Inflammatory AgentsOsteoarthritisPharmacologyBiochemistryOsteoarthritismedicineHumansCyclooxygenase InhibitorsProstaglandin E2AgedPharmacologyCyclooxygenase 2 InhibitorsChemistryCatabolismCartilageAnti-Inflammatory Agents Non-SteroidalInterleukinMembrane ProteinsAzepinesTriazolesmedicine.diseaseIsoenzymesInterleukin 10Cytokinemedicine.anatomical_structureCartilageBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesFemalemedicine.drugBiochemical pharmacology
researchProduct